Apollo Hospitals Pune is hosting the International MIS Spine Course from 5–8 August 2026, in collaboration with AOSYS Pvt. Ltd., one of India's leading manufacturers of orthopedic and spine implants, and with the support of the AOSYS Research and Training Foundation. The four-day educational initiative will bring together eminent spine surgeons and healthcare professionals from around the world to share expertise, advance surgical skills and explore the latest innovations in Minimally Invasive Spine (MIS) Surgery. The event reflects Apollo Hospitals' continued commitment to strengthening surgical excellence through international collaboration, knowledge exchange and continuous medical education.     Designed for orthopedic surgeons, neurosurgeons and spine specialists, the course offers an immersive learning experience through live surgical demonstrations, interactive case-based discussions and evidence-based lectures. Participants will gain practical insights into contemporary MIS spine techniques from renowned faculty, including Dr. Rajesh Parasnis, Orthopedic and Spine Surgeon at Apollo Hospitals Pune, and Dr. Sachin Pathak, Spine Surgeon at Sahyadri Hospitals, Pune. The programme is designed to strengthen surgical expertise, promote evidence-based techniques and support informed clinical decision-making in spine care.   Beyond technical training, the course serves as a forum for multidisciplinary collaboration, enabling clinicians to exchange best practices, discuss challenging cases and explore emerging innovations shaping the future of spine surgery. By bringing together global expertise and evidence-based practice, the International MIS Spine Course reinforces Apollo Hospitals Pune's position as a centre of excellence for clinical education, research and innovation. Through initiatives such as these, the hospital remains committed to advancing the standards of spine care and improving outcomes for patients and the wider healthcare community.

Dr. Vanita Arora, Cardiac Electrophysiologist & Interventional Cardiologist at Indraprastha Apollo Hospitals, Delhi, has been honoured with the ET Award for Excellence 2026 in Cardiac Electrophysiology at the ET Health Panel Discussion & Award Ceremony. The accolade recognises her outstanding contributions to the advancement of cardiac electrophysiology and her dedication to delivering exceptional patient care.    Cardiac electrophysiology plays a vital role in diagnosing and treating heart rhythm disorders, enabling timely, evidence-based care that improves patient outcomes. Dr. Arora has consistently advanced the field through expertise in arrhythmia management and innovative cardiac therapies. The Cardiac Electrophysiology team at Indraprastha Apollo Hospitals, led by Dr. Arora, recently performed India’s first leadless pacemaker implantation through a metallic prosthetic tricuspid valve, marking a significant milestone in complex cardiac care.   This latest recognition reflects not only individual achievement but also the continued commitment of Indraprastha Apollo Hospitals to advancing specialised cardiac care through clinical excellence, innovation and compassionate, patient-centred practice. By fostering expertise that translates into better diagnosis, safer procedures and improved outcomes, Apollo remains focused on strengthening the future of cardiovascular care and delivering world-class treatment for patients with complex heart rhythm disorders.

Dr. Sanjay Tyagi, Senior Consultant – Cardiology & Clinical Lead, Cardiology, Apollo Hospitals Group (Northern Region), who practises at Indraprastha Apollo Hospitals, New Delhi, has been conferred the prestigious Fellowship of the Japanese Circulation Society (FJCS). This distinguished international honour recognises his outstanding contributions to cardiovascular medicine, clinical excellence, and medical innovation.    The fellowship acknowledges Dr. Tyagi's longstanding commitment to advancing interventional cardiology, improving patient outcomes, and championing evidence-based cardiovascular care. Throughout his career, he has played a pivotal role in adopting advanced cardiac interventions, managing complex cardiovascular conditions, and contributing to medical education by mentoring and training future generations of cardiologists.   The recognition was commemorated in the presence of Dr. Prathap C. Reddy, Founder and Chairman, Apollo Hospitals Group, whose vision of delivering world-class, patient-centred healthcare continues to inspire excellence across the Apollo Hospitals network.   As cardiovascular disease remains one of the leading causes of morbidity and mortality worldwide, recognising clinicians who drive research, innovation, and high-quality patient care underscores the importance of continued excellence in improving cardiovascular outcomes. Dr. Tyagi's achievement reflects Apollo Hospitals' unwavering commitment to fostering clinical leadership, embracing global best practices, and delivering compassionate, evidence-based care. It also reinforces Apollo Hospitals' legacy as a leader in cardiovascular medicine and its continued dedication to advancing healthcare through clinical expertise, innovation, and better patient outcomes. 

Recognising the profound impact of clinical leadership and medical education, Dr. Reena Sethi, Senior Consultant - Ophthalmology at Indraprastha Apollo Hospitals, has been honoured with the prestigious Dronacharya Award at International YOSICON (Young Ophthalmologists Society of India) 2026. The award recognises her exceptional contributions to ophthalmic education, mentorship and clinical excellence, reflecting her unwavering commitment to advancing eye care and nurturing future specialists.    The honour celebrates Dr. Sethi's longstanding dedication to training young ophthalmologists through exemplary teaching, professional guidance and evidence-based clinical practice. By fostering a culture of continuous learning and maintaining high clinical standards, she has played a pivotal role in strengthening ophthalmic practice and improving patient outcomes. Her work underscores the vital role of medical education in ensuring that advances in ophthalmology are translated into safe, effective and high-quality patient care.   At Apollo Hospitals, clinical excellence is rooted in innovation, lifelong learning and compassionate care. By recognising clinician-educators such as Dr. Sethi, the organisation highlights the importance of mentorship, collaboration and continuous learning in advancing ophthalmic care and preparing future specialists. Her achievement reflects the enduring value of leadership in medicine and further strengthens Apollo Hospitals' commitment to delivering patient-centred, evidence-based healthcare through clinical excellence and education.

 Apollo Hospitals and CareClinics Healthcare Services, Malaysia, have formalised a strategic partnership through the signing of a Memorandum of Understanding (MoU) to advance continuing medical education (CME), foster clinical knowledge exchange, and strengthen evidence-based clinical practice. Signed by Dr. Preetha Reddy, Executive Vice Chairperson of Apollo Hospitals, and Datuk Dr. Thirunavukarasu Rajoo, Chief Executive Officer of CareClinics Healthcare Services, the MoU establishes a framework for professional development, collaborative learning, and the exchange of clinical expertise to further enhance healthcare excellence.    The partnership will facilitate structured learning opportunities for healthcare professionals, enabling clinicians from both organisations to share expertise, explore emerging evidence, and enhance their clinical capabilities. By promoting collaborative learning and the adoption of evidence-based clinical practices, the initiative aims to help maintain consistently high standards of patient care across diverse healthcare settings.   As healthcare becomes increasingly interconnected, international collaborations are playing a vital role in strengthening clinical capabilities and accelerating the exchange of global best practices. Through this alliance, Apollo Hospitals and CareClinics aim to create sustained opportunities for continuous learning, professional development, and clinical innovation, while advancing excellence in patient care and improving health outcomes.   The partnership reflects both organisations' shared commitment to advancing healthcare through education, innovation, and cross-border collaboration. By strengthening clinical capabilities, fostering continuous professional learning, and encouraging the exchange of knowledge and expertise, Apollo Hospitals and CareClinics aim to improve patient outcomes and contribute to the ongoing advancement of high-quality, evidence-based, patient-centred healthcare for the communities they serve.

Dr. Venugopal Balaji, Senior Consultant – Vascular Surgery, Apollo Hospitals, Greams Road, Chennai, has been featured in the Forbes India 18th Anniversary Edition in recognition of his contributions to vascular surgery, clinical excellence, and patient care innovation. The feature celebrates his longstanding commitment to advancing vascular care while reinforcing Apollo Hospitals' legacy of delivering world-class, evidence-based healthcare.   Vascular surgery plays a critical role in the diagnosis and treatment of conditions affecting the arteries and veins, including abdominal aortic aneurysms, carotid artery disease, peripheral arterial disease, deep vein thrombosis, diabetic foot complications, and varicose veins. Timely diagnosis and appropriate treatment can help prevent serious complications such as stroke, limb loss, and life-threatening vascular emergencies.   Over the course of his career, Dr. Balaji has contributed to the advancement of both open and endovascular vascular surgery through clinical expertise, academic research, and medical education. He established one of Chennai's first dedicated vascular surgery units at Apollo Hospitals, Greams Road, expanding access to specialized vascular care. Beyond his clinical practice, he has authored numerous scientific publications and has played an active role in training future vascular surgeons and promoting greater awareness of vascular diseases.   This recognition reflects Apollo Hospitals Chennai's continued commitment to clinical leadership, innovation, and excellence in patient-centred care while advancing specialized vascular services that improve outcomes and quality of life for patients with complex vascular conditions.

Apollo Spectra Hospitals, Chennai has been honoured with the National Award for Excellence in Multi-Specialty Care at the Financial Express Healthcare Summit & Awards 2026, recognizing the organization's commitment to delivering high-quality, patient-centred care across a broad range of surgical and medical specialties.   The recognition reflects Apollo Spectra Hospitals' continued focus on clinical excellence, evidence-based care, and multidisciplinary expertise, delivered by experienced clinicians and supported by advanced infrastructure. With a network of specialty hospitals across India, Apollo Spectra provides comprehensive surgical and specialty services across multiple disciplines, helping patients access high-quality care closer to home.   This national recognition reinforces Apollo Spectra Hospitals' commitment to maintaining high standards of quality, safety, and compassionate care while continuously enhancing the patient experience. The organization expressed gratitude to its patients for their continued trust, noting that the award inspires its ongoing pursuit of innovation and excellence in healthcare.

Apollo Hospitals Sheshadripuram has introduced iTIND (Temporary Implantable Nitinol Device), an advanced minimally invasive treatment for Primary Bladder Neck Obstruction (PBNO) and select benign prostatic conditions. With this launch, the hospital becomes the first in Bengaluru and Karnataka to offer iTIND and the first in the state to successfully complete 10 procedures using iTIND.   Although urinary obstruction is commonly associated with aging and enlarged prostates, PBNO can also affect younger men and often goes unrecognised. Symptoms such as a weak urinary stream, increased urinary frequency, and difficulty urinating are often overlooked, delaying diagnosis and increasing the risk of chronic bladder dysfunction, recurrent urinary tract infections, and, in severe cases, kidney damage. Early evaluation is therefore essential to prevent long-term complications.   To address this unmet need, the iTIND system offers a tissue-sparing alternative to conventional surgery. Inserted through a brief endoscopic procedure under mild sedation, the temporary device gently reshapes the bladder neck and prostatic urethra over five to seven days before being removed during a short follow-up visit. For appropriately selected patients, the procedure relieves urinary obstruction while preserving ejaculatory function and fertility.   Dr. T. Manohar, Chief Urologist, Uro-Oncologist & Transplant Surgeon at Apollo Hospitals Sheshadripuram, noted that many young men live with urinary symptoms for years because these problems are often mistakenly considered age-related. He emphasised that timely diagnosis could prevent long-term bladder damage, while iTIND offers effective symptom relief without compromising sexual or reproductive health in suitable candidates.   Mr. Uday Davda, Vice-President, Apollo Hospitals Sheshadripuram, said the introduction of iTIND reflects the hospital's commitment to expanding patient-centred, minimally invasive treatment options while promoting earlier diagnosis through advanced technologies.   The introduction of iTIND further strengthens Apollo Hospitals Sheshadripuram's comprehensive urology program, which includes HoLEP, MoLEP, Mini-MoLEP, Rezūm, UroLift, and robotic-assisted surgery, enabling specialists to tailor treatment to each patient's clinical needs. Medical experts also advise young men experiencing persistent urinary symptoms to seek timely evaluation, as simple diagnostic tests such as uroflowmetry can help detect bladder outlet obstruction early, helping prevent complications and preserve long-term bladder health. 

Apollo Hospitals has been recognised as the “Iconic Multi-Speciality Hospital” by Navabharat Times in 2026, reflecting the trust of its patients and the unwavering dedication of its doctors, nurses, and every member of the Apollo family. The recognition reinforces Apollo Hospitals' position as one of India's leading integrated healthcare providers and acknowledges its continued commitment to delivering high-quality, evidence-based healthcare.  Over the years, Apollo Hospitals has transformed healthcare delivery by combining advanced medical technologies with highly specialised clinical expertise across a broad range of medical and surgical disciplines. Its integrated model of care brings together preventive health services, diagnostics, specialised treatment, critical care, rehabilitation, and follow-up within a coordinated healthcare ecosystem, supporting timely diagnosis and improved patient outcomes.  The recognition also highlights Apollo Hospitals' continued investment in digital health, clinical research, advanced infrastructure, quality improvement, and patient safety. By embracing innovation while maintaining internationally benchmarked clinical standards, Apollo Hospitals remains committed to expanding access to trusted, patient-centred healthcare.  This honour reaffirms Apollo Hospitals' patient-first philosophy and its ongoing commitment to advancing clinical excellence, innovation, and compassionate care to meet the evolving healthcare needs of communities across India.

Apollo Hospitals has signed a Memorandum of Understanding (MoU) with The ePlane Company, a Chennai-based aerospace start-up, to explore India’s first electric air ambulance network. The collaboration aims to integrate electric air ambulances and medical delivery drones into Apollo’s emergency care ecosystem, to support faster access to specialized care for patients in both urban and remote regions.    Timely access to care during the "golden hour" following trauma, stroke, or cardiac emergencies can significantly improve patient outcomes. By combining The ePlane Company’s electric aircraft and drone technologies with Apollo Hospitals’ nationwide hospital network and 1066 ambulance services, the partnership aims to reduce transport delays and support faster patient transfers, organ transport, and delivery of critical medical supplies.  Dr. Prathap C. Reddy, Founder and Chairman, Apollo Hospitals Group, emphasized that too many lives in India are lost because emergency medical help cannot reach patients in time. He noted that the collaboration with The ePlane Company reflects Apollo Hospitals' commitment to extending its clinical expertise to every corner of the country, including remote and underserved regions.  Prof. Satya Chakravarthy, Founder & CTO, The ePlane Company, highlighted that every minute is critical during a medical emergency. He said the collaboration will explore how electric aircraft and drones can help shorten the time between an accident and definitive treatment, particularly for millions of Indians living far from specialized trauma care.  The collaboration will also evaluate the deployment of The ePlane Company’s e200X electric air ambulance platform and Amber Wings medical drones, subject to regulatory approvals and operational feasibility, further advancing technology-enabled emergency care across India.

The four women leaders of Apollo Hospitals — Dr. Suneeta Reddy, Dr. Preetha Reddy, Dr. Sangita Reddy, and Ms. Shobana Kamineni — have been jointly ranked No. 3 in the Fortune India 100 Most Powerful Women 2026 rankings, recognising their collective leadership in building one of India's most trusted healthcare organisations.  Under their leadership, the Apollo Hospitals Group has strengthened its position as one of Asia's leading integrated healthcare providers by advancing clinical excellence, expanding access to specialised care, and driving digital innovation. Their strategic vision has supported the growth of a nationwide healthcare network that combines advanced medical technologies, multidisciplinary expertise, and evidence-based practice to improve patient outcomes across diverse communities.   The recognition also reflects Apollo Hospitals' enduring commitment to making high-quality healthcare more accessible while advancing innovation in digital health, artificial intelligence, preventive care, and precision medicine. Guided by a patient-first approach, the organisation continues to invest in clinical research, advanced infrastructure, and workforce development to address the evolving healthcare needs of India and beyond.   This recognition highlights the growing influence of women in shaping the future of healthcare leadership while reinforcing Apollo Hospitals' mission to deliver compassionate, evidence-based, and globally relevant care. 

Apollo Hospitals has been recognised as the ET Family Business of the Year – Mega at the 2026 Economic Times Family Business Awards, recognising its enduring contribution to advancing healthcare in India through visionary leadership, clinical excellence and a steadfast commitment to patient care. The award celebrates family-led enterprises that have demonstrated sustained excellence, resilience and lasting impact within their industries.   Founded by Dr. Prathap C. Reddy, Apollo Hospitals has grown into one of Asia's leading integrated healthcare providers while remaining true to its founding mission of making world-class healthcare more accessible. Over nearly four decades, the organisation has advanced healthcare through multidisciplinary expertise, cutting-edge medical technologies, digital innovation and evidence-based clinical practice, improving outcomes for millions of patients.   Dr. Prathap C. Reddy, Founder Chairman, Apollo Hospitals Enterprise Ltd, called the award a tribute to the values and shared purpose that have guided Apollo Hospitals since its inception. Reflecting on his vision of making world-class healthcare accessible to every Indian, he acknowledged the contributions of his daughters along with Apollo's leadership, clinicians, nurses and employees in building an institution that continues to shape the future of healthcare in India, dedicating the honour to the entire Apollo family.   Dr. Suneeta Reddy, Managing Director, Apollo Hospitals Enterprise Ltd, said that Apollo will continue expanding its impact through innovation, technology and strategic partnerships while creating greater value across the healthcare ecosystem with patients at its centre. Ms. Shobana Kamineni, Executive Chairperson, Apollo HealthCo and Apollo Pharmacies, highlighted the strength of the sisters' collaborative leadership. Dr. Sangita Reddy, Joint Managing Director, Apollo Hospitals Enterprise Ltd, expressed gratitude to patients, shareholders and Apollo's employees for their continued trust, confidence and dedication. Dr. Preetha Reddy, Executive Vice-Chairperson, Apollo Hospitals Enterprise Ltd, acknowledged the contributions of her three sisters, emphasising that they have always worked as equals in building the institution together and that shared leadership has remained central to Apollo's journey.   This recognition reinforces Apollo Hospitals' commitment to advancing compassionate, evidence-based healthcare while driving clinical excellence, innovation and trust for patients, healthcare professionals and communities across India.